Capitale Ordinario Cambiamento Data
Cara Therapeutics USD 9.38M 9.38M 2025-09
Clal Biotechnology ILS 1.61M 0 2022-12
Compugen USD 94.55M 1.02M 2025-12
Cronos Group USD 382.89M 286.14M 2025-09
RedHill Biopharma USD 33.3B 20.4B 2025-06